Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality

BACKGROUND: Prostate cancer is a clinically heterogeneous disease with a subset of patients rapidly progressing to lethal‐metastatic prostate cancer. Current clinicopathological measures are imperfect predictors of disease progression. Epigenetic changes are amongst the earliest molecular changes in...

Descripción completa

Detalles Bibliográficos
Autores principales: Pidsley, Ruth, Lam, Dilys, Qu, Wenjia, Peters, Timothy J., Luu, Phuc‐Loi, Korbie, Darren, Stirzaker, Clare, Daly, Roger J., Stricker, Phillip, Kench, James G., Horvath, Lisa G., Clark, Susan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523674/
https://www.ncbi.nlm.nih.gov/pubmed/36178085
http://dx.doi.org/10.1002/ctm2.1030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523674/
https://www.ncbi.nlm.nih.gov/pubmed/36178085
http://dx.doi.org/10.1002/ctm2.1030

Ejemplares similares